FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052666246> ?p ?o ?g. }

• W2052666246 endingPage "952" @default.
• W2052666246 startingPage "944" @default.
• W2052666246 abstract "Objective: Decreased oxygen supply is generally accepted as the primary cause of muscle dysfunction in patients with peripheral arterial occlusive disease (PAOD) and intermittent claudication, although reported morphologic changes in the mitochondria of claudicating muscle suggest that impaired energy utilization may also play a role. With the measurement of the phosphate-rich compounds of muscle energy metabolism (adenosinetriphosphate [ATP], adenosinediphosphate [ADP], and phosphocreatine [PCr]) and pH, phosphorus P 31 magnetic resonance spectroscopy (31P MRS) provides a unique, noninvasive method to investigate this hypothesis further. Methods: Calf muscle bioenergetics were studied in 12 men with moderate claudication (ankle-brachial index ≥0.5 and ≤0.8) and 14 normal control subjects with the use of 31P MRS and standard treadmill testing. Phosphorus MRS evaluation of the superficial posterior calf muscles was carried out with a 90-second submaximal isometric plantar flexion exercise. This mild exercise was chosen to permit in-magnet testing and to allow study of intrinsic mitochondrial efficiency under conditions of unchallenged blood flow. Phosphocreatine and ADP recovery time constants (t.c.), two very sensitive measures of oxidative mitochondrial function, as well as intracellular pH and ATP production via anaerobic glycolysis were determined during three exercise sessions and the results averaged and compared to known values obtained from a control population. Results: During the 31P MRS protocol, the end exercise intracellular pH (7.11 ± 0.01 vs 7.11 ± 0.01) and ATP production by anaerobic glycolysis (0.13 ± 0.05 vs 0.14 ± 0.03 mmol/L per second) were no different in PAOD patients versus control subjects, confirming that the protocol exercise did not significantly reduce oxygen supply. Phosphocreatine and ADP recovery t.c. (137 ± 41 vs 44 ± 3 seconds and 60 ± 10 vs 29 ± 2 seconds, respectively) were significantly slower than normal (P <.05, t test). There was, however, no correlation between these measures of mitochondrial function and any treadmill parameter (P >.5, Pearson moment correlation). Conclusions: Phosphorus 31 MRS provides the first direct evidence of defective energy metabolism in the mitochondria of claudicating calf muscle. This defect appears to be independent of both arterial flow and the severity of occlusive disease in patients with mild to moderate claudication. Coupled with documented ultrastructural and DNA abnormalities in the mitochondria of claudicating skeletal muscle, these data provide evidence for a secondary cause of muscle dysfunction in intermittent claudication. (J Vasc Surg 2000;31:944-52.)" @default.
• W2052666246 created "2016-06-24" @default.
• W2052666246 creator A5005471358 @default.
• W2052666246 creator A5010315363 @default.
• W2052666246 creator A5030207568 @default.
• W2052666246 creator A5040626094 @default.
• W2052666246 creator A5077701768 @default.
• W2052666246 date "2000-05-01" @default.
• W2052666246 modified "2023-10-14" @default.
• W2052666246 title "Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle" @default.
• W2052666246 cites W1534958267 @default.
• W2052666246 cites W160584047 @default.
• W2052666246 cites W1779654951 @default.
• W2052666246 cites W1786604681 @default.
• W2052666246 cites W1787069486 @default.
• W2052666246 cites W1966518634 @default.
• W2052666246 cites W1977923285 @default.
• W2052666246 cites W1980218842 @default.
• W2052666246 cites W1993051807 @default.
• W2052666246 cites W1996689777 @default.
• W2052666246 cites W1996691305 @default.
• W2052666246 cites W1997451914 @default.
• W2052666246 cites W2007712698 @default.
• W2052666246 cites W2011060430 @default.
• W2052666246 cites W2013284189 @default.
• W2052666246 cites W2030404294 @default.
• W2052666246 cites W2032590401 @default.
• W2052666246 cites W2034615901 @default.
• W2052666246 cites W2050883291 @default.
• W2052666246 cites W2063707356 @default.
• W2052666246 cites W2065123079 @default.
• W2052666246 cites W2067946157 @default.
• W2052666246 cites W2079029234 @default.
• W2052666246 cites W2081923731 @default.
• W2052666246 cites W2133586066 @default.
• W2052666246 cites W2155942116 @default.
• W2052666246 cites W2156044035 @default.
• W2052666246 cites W2169557264 @default.
• W2052666246 cites W2415365813 @default.
• W2052666246 cites W364005502 @default.
• W2052666246 doi "https://doi.org/10.1067/mva.2000.106421" @default.
• W2052666246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10805885" @default.
• W2052666246 hasPublicationYear "2000" @default.
• W2052666246 type Work @default.
• W2052666246 sameAs 2052666246 @default.
• W2052666246 citedByCount "96" @default.
• W2052666246 countsByYear W20526662462012 @default.
• W2052666246 countsByYear W20526662462013 @default.
• W2052666246 countsByYear W20526662462014 @default.
• W2052666246 countsByYear W20526662462015 @default.
• W2052666246 countsByYear W20526662462016 @default.
• W2052666246 countsByYear W20526662462017 @default.
• W2052666246 countsByYear W20526662462018 @default.
• W2052666246 countsByYear W20526662462019 @default.
• W2052666246 countsByYear W20526662462020 @default.
• W2052666246 countsByYear W20526662462021 @default.
• W2052666246 countsByYear W20526662462022 @default.
• W2052666246 countsByYear W20526662462023 @default.
• W2052666246 crossrefType "journal-article" @default.
• W2052666246 hasAuthorship W2052666246A5005471358 @default.
• W2052666246 hasAuthorship W2052666246A5010315363 @default.
• W2052666246 hasAuthorship W2052666246A5030207568 @default.
• W2052666246 hasAuthorship W2052666246A5040626094 @default.
• W2052666246 hasAuthorship W2052666246A5077701768 @default.
• W2052666246 hasBestOaLocation W20526662461 @default.
• W2052666246 hasConcept C100206155 @default.
• W2052666246 hasConcept C103486182 @default.
• W2052666246 hasConcept C126322002 @default.
• W2052666246 hasConcept C134018914 @default.
• W2052666246 hasConcept C134897140 @default.
• W2052666246 hasConcept C164705383 @default.
• W2052666246 hasConcept C185592680 @default.
• W2052666246 hasConcept C1862650 @default.
• W2052666246 hasConcept C20251656 @default.
• W2052666246 hasConcept C2777466421 @default.
• W2052666246 hasConcept C2778626300 @default.
• W2052666246 hasConcept C2778963770 @default.
• W2052666246 hasConcept C2779881954 @default.
• W2052666246 hasConcept C2779959927 @default.
• W2052666246 hasConcept C28859421 @default.
• W2052666246 hasConcept C2908647359 @default.
• W2052666246 hasConcept C2986317502 @default.
• W2052666246 hasConcept C3018348675 @default.
• W2052666246 hasConcept C5140985 @default.
• W2052666246 hasConcept C55493867 @default.
• W2052666246 hasConcept C55885012 @default.
• W2052666246 hasConcept C62231903 @default.
• W2052666246 hasConcept C71924100 @default.
• W2052666246 hasConcept C79879829 @default.
• W2052666246 hasConcept C99454951 @default.
• W2052666246 hasConceptScore W2052666246C100206155 @default.
• W2052666246 hasConceptScore W2052666246C103486182 @default.
• W2052666246 hasConceptScore W2052666246C126322002 @default.
• W2052666246 hasConceptScore W2052666246C134018914 @default.
• W2052666246 hasConceptScore W2052666246C134897140 @default.
• W2052666246 hasConceptScore W2052666246C164705383 @default.
• W2052666246 hasConceptScore W2052666246C185592680 @default.
• W2052666246 hasConceptScore W2052666246C1862650 @default.

• next